Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?
Per Winkel, J Hilden, Jørgen Fischer Hansen, Per Hildebrandt, Jens Kastrup, Hans Jørn Kolmos, Erik Kjøller, Christian M. Jespersen, Christian Gluud, GB Jensen, Group CLARICOR Trial
Dyk ned i forskningsemnerne om 'Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?'. Sammen danner de et unikt fingeraftryk.